Navigation Links
10 Million Square Feet of Turf Set to be Treated in 2008 in Response to MRSA Outbreaks Nationwide
Date:1/8/2008

ROCHESTER HILLS, Mich., Jan. 8 /PRNewswire/ -- CSG/SportsCoatings, today announced approximately 10 million square feet of synthetic turf will be treated with its industry-leading antimicrobial coating, TurfAide(TM), in 2008 -- up from 1.5 million square feet in 2007.

The exponential increase in demand for TurfAide has been attributed to several factors, including a 2007 report in the Journal of the American Medical Association that found MRSA (methicillin-resistant Staphlycoccus aureas) is responsible for more than 94,000 serious infections and nearly 19,000 deaths each year. MRSA, a potentially deadly skin infection, is caused by staph bacteria that can survive on surfaces for days. The antimicrobial technology in TurfAide is proven to inhibit the growth of bacteria, fungi and mold for years with just one application.

According to three studies conducted by the Texas Department of State Health Services, the MRSA infection rate among football players is 16 times higher than the average person. Texas has synthetic turf at 18 percent of its high school fields.

"Schools, professional teams and recreation centers are recognizing the growing threat of sports-related infections," said CSG/SportsCoatings CEO Craig Andrews. "More synthetic turf systems will be treated with TurfAide than all other antimicrobial products combined in 2008; because it's a proven and powerful technology that's been safely used in medical and consumer goods for over 30 years."

"With bacterial infections like MRSA and fungi like ringworm affecting many student athletes across the country, the need to protect your facilities has become a necessity," said Jim Weaver, Virginia Tech University Athletics Director.

Virginia Tech University is one of many major Division I programs, National Football League franchises and high schools that have had their synthetic turf fields treated with TurfAide in the past 18 months. A small sampling of TurfAide clients includes: the NFL's New England Patriots, Minnesota Vikings, Cleveland Browns; the University of South Carolina and University of Tulsa; and the entire Plano Intermediate School District in Texas.

TurfAide made headlines in 2007 when the exclusive provider of AstroTurf(R) USA, General Sports Venue, made the choice to treat all of its turf systems with TurfAide at the factory level beginning in 2008.

"With infections such as staph and MRSA on the rise in the sports community, we are committed to providing the best defense available," said Michael Dennis, chairman of GSV.

Visit http://www.csgsportscoatings.com to find out more about the technology used in TurfAide.


'/>"/>
SOURCE CSG/SportsCoatings
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Romark Laboratories Raises $18 Million in Institutional Financing
2. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
3. NeuroVasx, Inc. Announces $8.5 Million Private Placement and Completion of cPAX Aneurysm Treatment Study
4. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
5. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
6. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
7. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
8. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
9. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
10. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):